Bezuclastinib

Bezuclastinib

SCHEMBL30177013

Cc1[nH]nc(C(=O)Nc2cnc3[nH]c(-c4ccccc4)cc3c2)c1C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KIT P10721 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bezuclastinib SCHEMBL29423018 1.00 KIT (1.00) KIT
SCHEMBL15824677 0.91 KIT (0.83) KIT
SCHEMBL15840046 0.89 KIT (0.80) KIT
SCHEMBL15824956 0.87 KIT (0.77) KIT
SCHEMBL15824327 0.87 KIT (0.77) KIT
SCHEMBL15824861 0.87 KIT (0.77) KIT
SCHEMBL15824096 0.87 KIT (0.77) KIT
SCHEMBL15825551 0.87 KIT (0.76) KIT
SCHEMBL15840071 0.86 KIT (1.00) KIT
SCHEMBL15840060 0.85 KIT (0.74) KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143168-A1 SYNTHESIS OF HETEROCYCLIC COMPOUNDS Plexxikon Inc. (US) 2023-03-08 EP disclosed
CN-115605460-A Synthesis of heterocyclic compounds 普莱希科公司(US) 2023-01-13 CN disclosed